According to a UK government announcement, thousands of young people in England will be offered a two-dose meningococcal B (MenB) vaccination ahead of the 2026 academic year as part of a one-off programme designed to reduce the risk of serious disease among students entering higher and residential further education.
The initiative follows a rise in MenB activity, including an outbreak in Kent earlier this year described by health officials as the largest and fastest-growing recorded in the UK. UK Health Security Agency (UKHSA) data indicate that 313 confirmed MenB cases were reported in England during 2024–2025, accounting for approximately 83% of all invasive meningococcal disease cases.
Thousands eligible for MenB vaccine
The programme will be available to individuals completing Year 13 in summer 2026, as well as those aged under 25 years who are starting university or moving into residential further education settings for the first time in autumn 2026. Eligible individuals will receive two vaccine doses at least 4 weeks apart, with vaccinations expected to begin from the end of July.
Health officials highlighted that first-year students face a substantially higher risk of invasive MenB disease than their non-student peers, owing to close and prolonged contact in shared accommodation and social settings. Cases of invasive meningococcal disease also typically peak during October and November.
Commenting on the programme, Deputy Chief Medical Officer Thomas Waite said: “There has been an increase in clusters of disease this year and so this one-off programme is designed to provide direct protection to those at highest immediate risk.”
MenB disease can cause severe complications, including amputations, hearing loss and neurological damage, and is associated with mortality rates of up to 10%. The vaccine is already included in the routine infant immunisation schedule, with evidence from the UK programme suggesting it has reduced MenB disease by around 75% among eligible vaccinated groups.
Continual assessment of MenB epidemiology
The Joint Committee on Vaccination and Immunisation is continuing to assess whether broader changes in MenB epidemiology warrant longer-term vaccination recommendations. In the meantime, public health authorities said the targeted programme is intended to provide protection for those considered at highest immediate risk ahead of the autumn peak in disease incidence.
- Author:
